PLA2G4A and prostate carcinoma: In addition, FASN inactivation with siRNA in LNCaP cells reduces pseudopodia and invadopodia formation, cell adhesion, migration and invasion, and FASN inhibition negatively regulates PLA2G4A and HSD17B12 in several prostate cancer cell lines [33].